A study has found that an emerging class of GLP-1 weight-loss drugs suppresses eating for pleasure, or hedonic feeding, in ...

Looking for a good show on HBO Max this week, to put on after a long day of work? The legacy prestige service is definitely ...

Discussions about naloxone are becoming more commonplace in Colorado classrooms, as teachers seek to educate students amid ...

Once upon a time, a Houston head shop's trippy posters were on the walls of hippies and stoners across America.

MIT researchers found that chaotic laser light can transform into a precise, stable beam. This breakthrough enables much ...

Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine This voice experience is generated by AI. Learn more. This ...

Taking GLP-1s once meant injecting a shot with a monthly price tag of $1,000. Today, patients interested in the wildly popular weight-loss drugs can choose among different types of injectables and ...

Of all the millions of people who have tried weight-loss drugs such as Wegovy and Zepbound, nearly one in four people don’t respond to treatment. They lose little weight, or none at all, and see few ...

Scientists have identified a set of genetic variants that could help to explain why responses to obesity drugs vary markedly from person to person 1. The large sample size makes the findings ...

The GLP-1 weight loss drugs revolutionizing the treatment of obesity, diabetes and a slew of other diseases come with a major caveat: They don’t work for everyone. Some people experience profound ...

Different psychedelic drugs have a strikingly similar effect on networks in the brain, finds the most comprehensive analysis so far of the mind-altering substances. The work, published in Nature ...

If you’re someone with an early-morning work shift, a new drug could one day help you wake up in the morning better than coffee or an energy drink. A recent clinical trial studied the drug ...